Naimish Patel

Insider Reports History

Entity
Individual
Location
C/O Crispr Therapeutics, 105 West First Street, Boston, MA
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Naimish Patel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Medical Officer Restricted Stock Units 40K May 28, 2024 Direct
CRISPR Therapeutics AG Chief Medical Officer Stock Option (Right to Buy) 18.3K Oct 16, 2024 Direct

Insider Reports Filed by Naimish Patel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG Oct 16, 2024 1 $0 4 Oct 18, 2024 Chief Medical Officer
CRSP CRISPR Therapeutics AG May 28, 2024 2 $0 4 May 29, 2024 Chief Medical Officer
CRSP CRISPR Therapeutics AG May 28, 2024 0 $0 3 May 28, 2024 Chief Medical Officer